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Abstract 
 
The aim of this work was to develop swellable modified release (MR) isoniazid tablets using different 
combinations of polyvinyl acetate (PVAc) and sodium-carboxymethylcellulose (Na-CMC). Granules were prepared by moist 
granulation technique and then compressed into tablets. In vitro release studies for 12 hr were carried out in dissolution media 
of varying pH i.e. pH 1.2, 4.5, 7.0 and 7.5. Tablets of all formulations were found to be of good physical quality with respect 
to appearance (width and thickness), content uniformity, hardness, weight variation and friability. In vitro release data 
showed that increasing total polymer content resulted in more retarding effect. Formulation with 35% polymer content 
exhibited zero order release profile and it released 35% of the drug in first hr, later on, controlled drug release was observed 
upto the 12th hour. Formulations with PVAc to Na-CMC ratio 20:80 exhibited zero order release pattern at levels of studied 
concentrations, which suggested that this combination can be used to formulate zero order release tablets of water soluble 
drugs like isoniazid. Korsmeyer-Peppas modeling of drug release showed that non-Fickian transport is the primary 
mechanism of isoniazid release from PVAc and Na-CMC based tablets. The value of mean dissolution time decreased with 
the increase in the release rate of drug clearly showing the retarding behavior of the swellable polymers. The application of a 
mixture of PVAc to Na-CMC in a specific ratio may be feasible to formulate zero order release tablets of water soluble drugs 
like isoniazid. 
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Introduction 
 
Tuberculosis is a rampant infectious disease and is considered to be the foremost cause of death from a single 
microorganism. Annually worldwide, of the 8 million people who actively manifest the disease, 3 million die (Hara and 
Hickey, 2002). Tuberculosis (TB) has been declared a public health emergency by the World Health Organization (WHO). 
Isoniazid, rifampicin, pyrizinamide and ethambutol were earlier prescribed as separate formulations in TB control. WHO and 
International Union against Tuberculosis and Lung Disease recommend the use of fixed dose combination formulations of 
the essential anti-tuberculosis drugs to ensure adequate treatment of patients (Blomberg et al. 2001). Isoniazid is the most 
prescribed drug for the treatment and prophylaxis of tuberculosis. It is a highly water soluble drug and have a pKa of 7-7.5. 
Its bioavailability through out the intestinal tract proves it to be a strong candidate for sustained drug delivery (Mariappan and 
Singh, 2003). 
Swellable polymers have gained wide interest recently for formulation of controlled release tablets because of their 
non-toxic and erodible nature. Swellable polymers offer the advantage of initial high release which eliminates the 
requirement of separate loading doses. Na-CMC has been widely investigated for its drug release retarding capabilities which 
forms gel when hydrated and later on dissolves in dissolution media. PVAc is a water insoluble swellable polymer which has 
only been investigated alone and in combination with PVP in the form of Kollidon® SR (Reza et al. 2003) in formulating 
controlled release tablets. These findings offer a potential combination of Na-CMC and PVAc to be investigated for drug 
release retarding properties. 
Varying pH conditions throughout the gastrointestinal tract is an important factor influencing the drug release from 
the dosage form. This leads to affect the absorption of drug from the gastrointestinal tract. It is therefore necessary to study 
drug release at varying pH conditions. The British Pharmacopoeia 2007 (BP, 2007) gives insight into the various pH 
conditions at which the dissolution procedure should be conducted. Therefore, dissolution studies were conducted at varying 
pH conditions in this study.  
  In present study, a model of sustained release design has been implemented. The proposed formulation would also 
be useful for an individual having half life of isoniazid about 1 h and the desired concentration will be maintained. In fast 
acetylator persons as isoniazid is excreted through acetylation process in the liver. By this technique, a dosage form was 
formulated which would be released for about 12 h at almost constant drug level much above the MEC. In present study, 
different concentrations of single polymer and ratios of polymers i.e. PVAc and Na-CMC were used to prepare modified 
release swellable isoniazid tablets that were formed by moist granulation technique and compressed into tablets. These tablets 
were then evaluated in vitro by employing usual quality control tests specially the dissolution in different simulated media. 
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Materials and Methods 
Materials 
 
Isoniazid was a gift sample from Schazoo laboratories, Lahore, Pakistan. Polyvinyl acetate (PVAc) and sodium-
carboxymethylcellulose (Na-CMC) were purchased from Fluka, Germany. Avicel 101 was obtained from Merck, Germany. 
All other analytical grade chemicals i.e. potassium dihydrogen phosphate, sodium hydroxide, hydrochloric acid, magnesium 
stearate and talc were purchased from Merck, Germany. All the materials were used as such without further processing.    
 
Preparation of modified release swellable isoniazid tablets 
 
Twelve different formulations were prepared using wet granulation method. The composition of formulations are 
shown in Table 1. All ingredients were accurately weighed. Isoniazid, PVAc, Na-CMC and Avicel were mixed together for 
10 minutes in the pestle and mortar. Wet mass was prepared using water in a small quantity as a moistening agent for 
adhering the powder particles. The moist mass was then pressed through a screen (Mesh size 8) and granules were dried in a 
thermostatically controlled oven at 45 °C for 2 h. The granules were again passed through a screen (Mesh size 18). 
Magnesium stearate and talc were added to improve flow of granules from hopper to die cavity and to prevent adhesion of 
granules to punches. Then the granules were compressed using single punch tablet machine with oblong shaped concave 
punches with an average weight of each tablet 550 mg. Each formulation batch consisted of about 500 tablets. Drug content 
for each tablet was 300 mg per tablet. Total polymer concentrations used for preparation of swellable modified release tablets 
were 20%, 25%, 30% and 35%. The ratio of polymers at these concentrations and the composition of different ingredients per 
tablet in each formulation are given in Table 1 and 2, respectively. 
 
Physical evaluation of formulations 
 
The flow characteristics (angle of repose) of formulated granules, weight variation, hardness, friability and 
dimensional measurements of prepared tablets were measured as presented by Murtaza et al. (2009) and directed in USP30-
NF25 (2007). 
 
Drug contents determination 
 
Official method of BP was used to determine the INH contents of MR INH Swellable tablets. The 20 tablets from 
each formulation of swellable MR isoniazid tablets were taken and crushed. Quantity of crushed material equivalent to 100 
mg Isoniazid was taken and dissolved in 50 ml distilled water by stirring for 10 min. Then the volume was made up to 1000 
ml with distilled water. Now this solution was filtered. The 2 ml solution was taken and diluted to 20 ml with distilled water. 
This sample was analyzed spectrophotometrically at a λ max 263 nm and concentration was determined from the calibration 
curve. 
 
Preparation of calibration curves 
 
Isoniazid 100 mg was added to 50 ml distilled water, mixed with continuous stirring and placed in a sonicator so 
that the drug may completely dissolve. Then adequate volume of distilled water was added to make final volume to 1000 ml 
with strength of 100 μg/ml. This stock solution was further diluted to get 3, 9, 15, 21, 27, 33 and 39 μg/ml samples. The 
samples were analyzed at 263 nm using UV-VIS spectrophotometer (Schimadzu, Japan) and a standard curve was 
constructed as shown in Figure 1. The values of linearity are: slope = 0.03, Intercept = 0.1367 and coefficient of 
determination (R2) = 0.9971. Since there was significant variation in pH conditions during dissolution procedure and 
isoniazid, being weekly basic drug, gives different solubilities at different pH solutions, therefore it was necessary to make 
separate calibration curves for each of these pH variations for accurate determinations of isoniazid contents at a specific pH 
condition (Davidson, 2002). Above mentioned procedure was repeated for the preparation of calibration curve in HCl buffer 
of pH 1.2, pH 4.5, pH 7.0 and pH 7.5 phosphate buffer solutions. The values of linearity are given below: 
In HCl buffer of pH 1.2, Slope = 0.0297, Intercept = 0.1531 and R2 = 0.9975. 
In pH 4.5 phosphate buffer solution, Slope = 0.0299, Intercept = 0.1447 and R2 = 0.9976. 
In pH 7.0 phosphate buffer solution, Slope = 0.0299, Intercept = 0.14 and R2 = 0.9975. 
In pH 7.5 phosphate buffer solution, Slope = 0.03, Intercept = 0.1369 and R2 = 0.9968. 
 
Dissolution study 
 
All the solutions and buffers were prepared according to BP and United States Pharmacopoeia 2007 for preparation 
of calibration curve of drug, dissolution and swelling study of the prepared tablets. Dissolution was carried out in apparatus II 
according to “Modified Half Change Method” of BP to study the release of isoniazid at different pH which simulates the pH 
of almost entire GIT. The temperature and stirring of medium was kept constant at 37 °C + 0.5 °C and 50 rpm, respectively. 
The study was conducted for first 2 h in HCl buffer pH 1.2, then half of this was replaced with phosphate buffer pH 7.5 to 
attain pH 4.5. Then after 1.5 h, half of the medium was replaced with phosphate buffer pH 7.5 and pH was adjusted to 7.0. 
After 2 h, half of the medium was again replaced with phosphate buffer pH 7.5. All pH adjustments were carried out with 2 
M HCl and 2 M NaOH solutions (BP, 2007). The sampling time points were 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 h. Each 
time, 2 ml of the sample was withdrawn, further diluting it to 20 ml and analyzed by spectrophotometer. Each time sample 
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withdrawn was replaced by fresh dissolution medium and pH was rechecked. Dissolution of each formulation was done as 
triplicate and then mean of these values were taken. 
 
Kinetic and mechanistic analysis of drug release pattern 
 
The kinetic and mechanistic analysis of drug release pattern was evaluated using various model dependent (zero 
and first models, Higuchi, Hixson-Crowell, Korsmeyer-Peppas Models) and independent (mean dissolution time 
determination) approaches as mentioned previously (Murtaza et al. 2009). 
 
Swelling studies of tablets 
 
Swelling studies of tablets were conducted at room temperature at five different pH conditions. Four studies were 
conducted separately at constant pH values of 1.2, 4.5, 7.0 and 7.5. One study was conducted at varying pH conditions 
similar to those as the dissolution studies. Tablet weight was determined after zero hours, 1, 2, 3, 3.5, 4, 5, 5.5 and 6 h. For 
weight measurement of tablet, it was put out of the petri dish, blotted with the tissue paper each time to remove solvent 
present on its surface and was then weighed and placed in its buffer again. Each experiment was repeated five times and 
average weight gain in the form of percentage swelling by the tablets for each formulation at different pH conditions were 
plotted against time (USP30-NF25, 2007).  
Swelling Index (S.I.) or percentage swelling was calculated by the following formula 
S.I. = {(Ww-Wd)/ Wd} x 100  
Where Ww is the wet weight and Wd is the dry weight of the tablet at zero time of swelling. 
 
Table 1: Formulations of swellable modified release isoniazid tablets 
 
Formulation         A          B         C        D 
Total Polymer 
Contents 20% 25% 30% 35% 
PVAc to CMC 
ratios 
 PVAc:CMC  PVAc:CMC  PVAc:CMC  PVAc:CMC 
A1 80:20 B1 80:20 C1 80:20 D1 80:20 
A2 50:50 B2 50:50 C2 50:50 D2 50:50 
 
A3 20:80 B3 20:80 C3 20:80 D3 20:80 
  
 
Table 2: Composition of formulations of swellable modified release isoniazid tablets 
 
 
 
 
Results and Discussion 
Physical evaluation of formulations 
 
The values of angle of repose of the granules for all formulations showed good flow properties (acceptable angle of 
repose). Tablets of all the formulations showed satisfactory hardness and friability less than 1% which is in accordance to the 
limit specified by BP. All the formulations showed weight variation within limit of 5% and none of the tablets deviated more 
than 5% as specified by BP (Table 3). While the thickness and width of all tablets is given in Table 4. The drug content assay 
of all the formulations were within range as specified in BP and the assay results are given in following Table 4. 
Formulation 
code 
Isoniazid 
(mg) 
PVAc 
 (mg) 
Na-CMC 
(mg) 
Avicel 
 (mg) 
Magnesium 
Stearate (mg) 
Talc 
(mg) 
Quantity per 
Tablet (mg) 
A1 300 88 22 112.5 18.52 8.24 550 
A2 300 55 55 112.5 18.52 8.24 550 
A3 300 22 88 112.5 18.52 8.24 550 
B1 300 110 27.5 90 18.52 8.24 550 
B2 300 68.75 68.75 90 18.52 8.24 550 
B3 300 27.5 110 90 18.52 8.24 550 
C1 300 132 33 57.5 18.52 8.24 550 
C2 300 82.5 82.5 57.5 18.52 8.24 550 
C3 300 33 132 57.5 18.52 8.24 550 
D1 300 154 38.5 30 18.52 8.24 550 
D2 300 96.25 96.25 30 18.52 8.24 550 
D3 300 38.5 154 30 18.52 8.24 550 
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Table 3: Angle of repose of granules for all formulations 
 
 
 
 
             Table 4: Thickness, width and assay for all tablets 
 
Thickness (mm) Width (mm) Assay (mg) 
Formulation code 
Mean ± S.D. Mean ± S.D. Mean ± S.D. 
A1 5.495±0.08 8.1±0.05 300.17±0.47 
A2 5.49±0.02 8.1±0.04 300.13±0.43 
A3 5.49±0.03 8.1±0.06 300.11±0.65 
B1 5.48±0.03 8.1±0.05 300.08±0.38 
B2 5.49±0.04 8.1±0.04 300.01±0.98 
B3 5.5±0.04 8.1±0.01 300.17±1.08 
C1 5.5±0.05 8.1±0.02 300.1±0.26 
C2 5.49±0.03 8.1±0.03 300.07±0.25 
C3 5.49±0.02 8.1±0.04 300.17±0.50 
D1 5.48±0.04 8.1±0.02 299.95±0.76 
D2 5.48±0.03 8.1±0.05 300.12±0.66 
D3 5.49±0.02 8.1±0.05 299.88±0.65 
 
 
 
All the preparations i.e. A1, A2, A3, B1, B2, B3, C1, C2, C3, C4, D1, D2 and D3 were subjected to dissolution at 
varying pH and the results were obtained. The results elaborated that the combination of polymers as well as concentration of 
the polymers in the tablets both influenced release of water soluble drug from the tablets. 
Total polymer content of 20% of the tablet was evaluated for drug release at three levels i.e. polymer ratios of 
80:20, 50:50 and 20:80 of PVAc and Na-CMC in the form of A1, A2 and A3. The A1 and A2 showed initial burst release 
and 100% drug was released in 8 h where as from A3, 100% of the drug was released in 9 h. MDT values of A1, A2 and A3 
were found to be 2.22, 2.29 and 3.44 h, which showed that A3 had more release retarding efficacy. Release profiles are 
expressed in Figure 1. This initial burst release, in case of A1 and A2 might be attributed to higher PVAc to Na-CMC ratio 
which could not retard release of drug at lower level of Na-CMC. The A3 did not show such burst release which may be due 
to higher ratio of Na-CMC which formed gel and thus retarded drug release more than A1 and A2. The PVAc was present in 
higher amount only in A1, which caused initial burst release due to high swelling at lower pH. Other contributing factor for 
initial high release was slightly basic nature of isoniazid which dissolved more readily in acidic media, but this factor is of 
less importance owing to highly soluble nature of isoniazid in water. 
Total polymer content of 25% of the tablet was evaluated for drug release at three levels i.e. polymer ratios of 
80:20, 50:50 and 20:80 of PVAc and Na-CMC in the form of B1, B2 and B3. All the three formulations released 100% drug 
in 9 h. MDT values of B1, B2 and B3 were found to be 3.01, 3.09 and 3.45 h, which showed that B3 had more release  
Angle of 
repose (°) Hardness (N) Friability (%) Weight variation test 
 
Formu-
lation 
code Mean ± S.D. Mean ± S.D. Mean ± S.D. Mean weight (mg) ± S.D. 
A1 22.76± 0.25 0.118± 0.391 0.118± 0.06 550.03± 1.51 
A2 23.53± 1.28 0.126± 0.275 0.126± 0.05 550.17±1.50 
A3 23.67± 0.76 0.107± 0.993 0.107± 0.08 550.24± 1.45 
B1 23.16± 0.76 0.139± 0.906 0.139± 0.02 550.33± 1.72 
B2 22.83± 0.28 0.208± 0.110 0.208± 0.03 550.06± 2.04 
B3 29.50± 0.50 0.239± 0.894 0.239± 0.00 550.32± 1.99 
C1 25.50± 0.50 0.213± 0.043 0.213± 0.08 550.41± 1.70 
C2 22.76± 0.75 0.217± 0.819 0.217± 0.08 550.23± 1.89 
C3 26.63± 0.56 0.205± 0.978 0.205± 0.01 550.43± 1.66 
D1 25.90± 0.40 0.189± 0.013 0.189± 0.05 549.91± 1.40 
D2 22.90± 0.51 0.217± 0.731 0.217± 0.09 550.36± 1.88 
D3 25.63± 0.55 0.196± 0.677 0.196± 0.05 549.94± 1.96 
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Table 5: Kinetic analysis of dissolution data using various models on the basis of coefficient of determination 
 
MDT Zero order kinetics First order kinetics 
Higuchi 
Model Hixson Crowell Model 
Korsmeyer- Peppas 
Model Formulation 
code 
 R2 R2 R2 R2 R2 N 
A1 2.2290 0.8474 0.8264 0.9393 0.9600 0.9220 0.5063 
A2 2.2998 0.8415 0.7411 0.9283 0.9130 0.9069 0.4873 
A3 3.4482 0.9682 0.6972 0.9688 0.9023 0.9569 0.572 
B1 3.0138 0.9188 0.7893 0.9699 0.9184 0.9642 0.5557 
B2 3.0954 0.9692 0.7626 0.9757 0.9137 0.9708 0.4847 
B3 3.4586 0.9853 0.7399 0.9742 0.9177 0.9659 0.525 
C1 3.2174 0.8778 0.7102 0.9558 0.901 0.9308 0.5628 
C2 3.7736 0.9745 0.6864 0.9783 0.8961 0.9596 0.5375 
C3 3.5099 0.9004 0.871 0.9518 0.9751 0.9494 0.5495 
D1 3.3605 0.805 0.7457 0.9135 0.9102 0.9105 0.5954 
D2 4.0836 0.8669 0.981 0.9576 0.9714 0.8925 0.5961 
D3 3.8859 0.9525 0.9449 0.9912 0.9489 0.9684 0.5141 
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Figure 1: The effect of increased ratio of Na-CMC to PVAc with a constant amount of total polymer on dissolution profiles 
of different MR formulations A1, A2, A3. 
 
 
retarding efficacy. Release profiles are expressed in Figure 2. This initial burst release, in the case of B1 and B2 may be 
attributed to higher level of PVAc which could not retard release of drug at low presence of Na-CMC. B3 did not show such 
burst release which might be due to higher ratio of Na-CMC which formed gel and thus retarded drug release more than B1 
and B2. PVAc was present in higher amounts in B1 and B2 than in B3, which caused initial burst release due to high swelling 
at lower pH. Other contributing factor for initial high release was slightly basic nature of isoniazid which dissolved more 
readily in acidic media, but this factor is less important value owing to highly soluble nature of Isoniazid in water. Since Na-
CMC swelled latter on after increase in pH, therefore it led to the increase in drug release rate after an initial 2 h period and 
caused the tablets of B3 to completely release the drug in 9 h. 
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Figure 2: Influence of increased ratio of Na-CMC to PVAc with a constant amount of total polymer on dissolution profiles 
of different MR formulations B1, B2 and B3. 
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Figure 3: Influence of increased ratio of Na-CMC to PVAc with a constant amount of total polymer on dissolution profiles 
of different MR formulations C1, C2 and C3. 
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Figure 4: Influence of increased ratio of Na-CMC to PVAc with a constant amount of total polymer on dissolution profiles 
of different MR formulations D1, D2 and D3. 
 
 
 
 
 
 
Figure 5: Influence of varying ph on swelling index of swellable MR isoniazid tablets 
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Figure 6: Influence of total polymer content on swelling index of swellable MR isoniazid tablets at varying pH (Grey = 8:2, 
Blue = 5:5 and Black = 2:8) 
 
 
 
 
Figure 7: Influence of PVAc and NA-CMC ratio on swelling index of swellable MR isoniazid tablets in different pH 
environments 
 
 
 
When total polymer content of 30% of the tablet weight was evaluated for drug release at three levels i.e. polymer 
ratios of 80:20, 50:50 and 20:80 of PVAc and Na-CMC in the form of C1, C2 and C3, then C1 and C2 released 100% drug 
only in 10 hours whereas C3 released 100% drug in 11 hours. Only C1 showed initial burst release. MDT values of C1, C2 
and C3 were found to be 3.21, 3.77 and 3.50 hours, which showed that C2 had more release retarding efficacy. Release 
profiles are expressed in Figure 3. This initial burst release, in the case of C1 might be attributed to higher level of PVAc 
which could not retard release of drug at low presence of Na-CMC. C2 did not show such burst release probably due to 
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enough amount of Na-CMC which failed to swell at low. Also its swelling at higher pH values could not affect any 
significant drug release with increasing pH conditions. C3 also did not show such burst release which may be due to higher 
ratio of CMC which formed gel and thus retarded drug release more than C1. PVAc was present in higher amounts in C1 than 
in C2 and C3, which caused initial burst release due to high swelling at lower pH. Other contributing factor for initial high 
release was slightly basic nature of isoniazid which dissolved more readily in acidic media, but this factor is less important 
value owing to highly soluble nature of isoniazid in water. In the case of C3, Na-CMC swelled more with the increase in pH 
leading to increase in drug release from dosage form when dissolution media was changed to less acidic and later on basic pH 
conditions. 
When total polymer content of 35% of the tablet weight is evaluated for drug release at three levels i.e. polymer 
ratios of 80:20, 50:50 and 20:80 of PVAc and Na-CMC in the form of D1, D2 and D3, then 100% drug was released in D1 in 
10 hours, in 12 hours in D3 where as in D2, 93.20% drug released in 12 hours. MDT values of D1, D2 and D3 were found to 
be 3.36, 4.08 and 3.88 hours, which showed that D2 had more release retarding efficacy. . Release profiles are expressed in 
Figure 4. The initial high release, in the case of D1 might be attributed to higher level of PVAc which could not retard release 
of drug at low presence of Na-CMC. D2 and D3 did not show such high initial release which may be due to higher ratio of 
Na-CMC which formed gel and thus retarded drug release more than D1 and D2. PVAc was present in higher amounts in D1 
than in D2 and D3, which caused initial burst release due to high swelling at lower pH. Other contributing factor for initial 
high release was slightly basic nature of isoniazid which dissolved more readily in acidic media, but this factor is less 
important value owing to highly soluble nature of isoniazid in water.  
Tablets of D3 latter on, after about 4 hours, started to rotate with the dissolution media and ascended up to ¾ part of 
the dissolution flask. As compared to D2, it therefore allowed higher amount of drug to be released latter on, it might be due 
to the separation of gel formed around its surface which would otherwise retard the drug release from the tablets. The other 
factor for higher release from D3 than D2 was that the tablets of D3 swelled quite more than those of D2 allowing more drug 
to be released from D3. 
For water soluble slightly basic drugs such as isoniazid, overall effect of increasing total polymer content was 
increase in total dissolution time for 100 percent release of the drug from tablets as has been previously investigated for 
Kollidon SR (Reza et al. 2003).  Overall effect of increasing polymer content, with PVAc and Na-CMC used in the ratio of 
80:20, resulted in increasing total dissolution times for 100% release of the drug from the tablet and increased MDT but 
failed to minimize initial burst release due to higher ratio of PVAc to Na-CMC. Same results of varying polymer 
concentration at PVAc to Na-CMC ratio of 50:50 were obtained. The PVAc to CMC ratio of 20:80 also behaved similarly. 
Formulation number C3 released more percentage of the drug due to higher swelling of CMC at high concentration during 
early time of basic medium and started rotating and suspended in dissolution media which led to removal of gel layer on the 
tablet surfaces. This suspension and rotation of tablets might have occurred due to tablet’s lower density than water resulting 
from higher swelling of Na-CMC. Thus, this type of combination of Na-CMC and PVAc can be used in the formulation of 
floating tablet formulation as it had been previously used along with HPMC to formulate floating tablets (Narendra et al. 
2006). The D3 also started to rotate and suspended in dissolution media, but did not give higher release than C3. It occurred 
due higher polymer concentration present in the formulation which resulted in more release retarding effect. 
The in vitro modified release of Isoniazid from the tablets prepared using PVAc and Na-CMC were examined by 
performing dissolution tests under the following conditions. Conditions of dissolution tests: paddle method, pH 1.2, 4.5, 7.0, 
7.5, dissolution medium volume 1000 ml. and then different mathematical models were applied to analyze dissolution 
profiles. Isoniazid gave initial burst release in all the formulations due to its higher solubility in acidic media because of its 
high pKa (pKa= 7.5) and also due to swelling of the polymers in the tablets which allowed more water to come into contact 
with the drug. This initial burst release was more prominent in those formulations which contained PVAc and Na-CMC in the 
ratio of 8:2 which was might be due to less gel formation by the combination containing less amount of Na-CMC which 
otherwise retarded the drug release when present in high amount even in the presence of higher swelling ratios, this gelling 
effect of Na-CMC has been previously investigated with HPMC (Narendra et al. 2006).). 
The Higuchi model best explained the drug release data, according to which drug release is directly proportional to 
the square root of time, as its value of R2 was greater than 0.9135 for all formulations. Analysis of the dissolution profiles by 
the Hixson-Crowell model elaborated a change in surface area and diameter of the formulations with progressive dissolution 
of the matrix as a function of time. Anomalous diffusion was the mechanism of drug release from microparticles. According 
to the Korsmeyer-Peppas model, the value of “n” from 0.45 to 0.89 indicates the anomalous diffusion (Murtaza et al. 2009). 
The swelling and erosion of the matrix is likely to be responsible for such type of drug release from tablet matrix. The 
anomalous diffusion shows that drug transport is mainly governed by coupling of Fickian diffusion of the drug from the 
tablets and polymer relaxation and swelling. Polymer chain relaxation suggested as one of the main drug transport is the 
swelling of the polymer chain molecules which latter on causes the polymer chains to become mobile leading the polymer 
chains to form three fronts, one moving front at which swelling is taking place, it is called as swelling front and the other 
diffusion front which separates the un-dissolved drug from swelling front. The third front is the erosion front which separates 
the dosage form from dissolution medium (Siepmann and Siepmann, 2008). 
This value of n suggests that polymer relaxation and swelling of the tablets are the primary causes involved in the 
release of water soluble drugs and not the erosion of the polymers because if it would be the cause of release then n value 
would show super case transport. This finding in that study is in conformity to the previous work which suggests that water 
soluble drugs are released due to swelling and not because of erosion (Reza et al. 2003). The results of this mathematical 
analysis applied to all formulations of MR swellable isoniazid tablets are summarized in the table number 5. Although release 
rate constant K is the measure of drug release but it should not be used to characterize drug release due to the differences in 
drug release kinetics. Since MDT shows the drug release retarding efficacy of the polymers used in a formulation, there fore 
it was used for comparison of release profiles of different formulations. MDT was calculated to characterize drug release 
from dissolution data and to compare drug release in different formulations. For calculation of MDT, value of K and n were 
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calculated according Korsmeyer-Peppas equation. Mean Dissolution Time (MDT) was calculated from the following 
equation according to Mockel and Lippold (Mockel and Lippold, 1993). 
 
MDT = [n / (n + 1)] x K-1/n 
 
Here K is the kinetic constant and n is the release exponent calculated from Korsmeyer-Peppas equation, Mt / M∞ = K. tn. 
As the value of MDT increased with increasing total polymer content at specific ratios of polymers, it shows that increasing 
polymer content at all the three ratios of PVAc and CMC investigated in this study led to increase in MDT. So increase in 
polymer loading led to increased release retarding capability which was apparent from the higher MDT i.e. higher the 
polymer concentration, higher the MDT irrespective of the ratios of the polymers This finding is in accordance to the 
previous finding (Reza et al. 2003). 
In this study, it was found that as the polymer ratio changed while total polymer content remained constant, then 
values of MDT changed which showed their relative drug release retarding efficacies at a specific concentration. Table 5 
represents the values of MDT calculated for all the formulations along with their respective n and K values. 
Variation in pH conditions significantly affected swelling of PVAc and Na-CMC based isoniazid tablets at all pH 
conditions, except the effect of pH 1.2, which caused least swelling for formulations A1, B1, C1 and D1 which had higher 
contents of PVAc but other formulations showed higher swelling which was due to higher Na-CMC levels.  
Overall effect was that at pH 7.5 most of the formulations showed highest swelling. When varying pH condition was used to 
analyze swelling, then at higher pH levels, tablets showed continuous swelling, as soon as pH was increased, swelling index 
(S.I.) increased until most of the Na-CMC dissolved and tablet eroded. Figure 5 summarizes the effect of varying pH on S.I. 
of all the formulations. 
When the total polymer content was increased, then all the formulations showed higher swelling at all pH 
conditions. Also their increase resulted in prolongation of swelling effect. It occurred so because PVAc swells more at acidic 
pH where as Na-CMC swells more at higher pH, such a trend is shown from the figures of S.I. of all the formulations, from 
them it is apparent that all the formulations showed higher S.I. in Dynamically changing pH than at acidic pH. At pH 4.5, 7.0 
and 7.5, S.I. of each formulation was higher than the acidic pH 1.2. It shows that tablets of PVAc swells less at higher pH 
conditions where as tablets of Na-CMC swells more at higher pH conditions but also swells at acidic pH. Figure 6 
summarizes the effect of polymer content on S.I. of all the formulations. 
Formulations with same total polymer content but with PVAc to Na-CMC ratio 80:20 showed lower S.I. than those 
of PVAc to Na-CMC ratio of 50:50 and 20:80. This means that when Na-CMC to PVAc ratio was increased, then the tablets 
showed higher swelling Index. Increasing ratio of Na-CMC in the formulations resulted in increasing S.I. and more gel 
formation which is in similarity to the previous finding in which Na-CMC was used in combination with HPMC (Efentakis et 
al. 1997). Figure 7 shows that Na-CMC increased Swelling Index of the tablets in every pH environment studied when PVAc 
was replaced by Na-CMC in formulations. So it can be assumed from this finding that in the case of PVAc and NaCMC 
based isoniazid tablets, amount of Na-CMC significantly affects swelling index as compared to PVAc. Figure 7 summarizes 
the effect of polymer ratios on S.I. of all the formulations. 
 
Conclusion 
 
On the basis of this study, it is concluded that a model of sustained zero order release formulation with initial high 
release and later slow release to sustain drug plasma concentration can be successfully implemented on the swellable 
modified release isoniazid tablets. 
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